1CVS Stock Chart & Stats
€94.70
€0.60(0.64%)
At close: 4:00 PM EDT
€94.70
€0.60(0.64%)
Day’s Range― - ―
52-Week Range€33.00 - €140.00
Previous CloseN/A
Volume0.00
Average Volume (3M)44.00
Market Cap
€116.37B
Enterprise Value€158.57K
Total Cash (Recent Filing)€11.80B
Total Debt (Recent Filing)€78.34B
Price to Earnings (P/E)45.2
Beta0.07
Next Earnings
Aug 05, 2026EPS Estimate
1.6Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.31
Shares Outstanding1,275,927,200
10 Day Avg. Volume88
30 Day Avg. Volume44
Financial Highlights & Ratios
PEG Ratio-0.92
Price to Book (P/B)1.34
Price to Sales (P/S)0.25
P/FCF Ratio12.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€97.07Price Target Upside2.51% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering17
EPS Forecast (FY)6.54
Revenue Forecast (FY)€359.09B
Bulls Say, Bears Say
Bulls Say
Vertical Integration & Diversified ModelCVS’s integrated model (Aetna, Caremark, retail pharmacy) creates durable cross-segment synergies: it can steer volume to owned channels, coordinate care to lower medical costs, and capture multiple margin pools. This structural edge supports membership retention and long-term cash flow diversification.
Strong Cash GenerationSustained OCF (~$10.3B TTM) and FCF (~$7.4B TTM) provide durable funding for debt reduction, capital investment and dividends. Reliable cash conversion underpins financial flexibility to invest in technology, care delivery and strategic initiatives even if margins stay pressured.
Insurance (Aetna) Margin RecoveryMaterial AOI gains and a markedly improved MBR at Aetna reflect durable underwriting and care-management improvements. Management’s return-to-target-margin plan through 2028 suggests sustained earnings recovery in the Health Care Benefits segment, which stabilizes enterprise profitability over the medium term.
Bears Say
Compressed Profitability TrendsDespite strong revenue scale, margins and returns have materially compressed, reducing earnings power and ROE. A multi-year decline in gross and net margins indicates structural cost and reimbursement pressure that could limit free cash flow upside absent sustained margin recovery initiatives.
PBM Profit & Rebate PressuresRebate guarantees, client price concessions and mix shifts are pressuring Health Services AOI. Given PBM contract dynamics and regulatory scrutiny, PBM spread margins may remain structurally compressed, making PBM earnings volatility and lower steady-state profits a medium-term risk to enterprise cash flow.
Regulatory And State-level UncertaintyFragmented state rules and evolving federal policy on PBMs and pharmacy reimbursement can impose higher operating costs and limit routing of volume to owned channels. Persistent regulatory uncertainty risks structural margin erosion and increases compliance and litigation costs over the next several quarters.
CVS Health News
1CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was €33.00 and its highest was €140.00 in the past 12 months.
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is €116.37B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Aug 05, 2026 which is in 3 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on May 06, 2026. The company reported €2.228 earnings per share for the quarter, beating the consensus estimate of €1.893 by €0.335.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp does not currently pay dividends.
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 1.6.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,275,927,200 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of €2.228 in its last earnings report, beating expectations of €1.893. Following the earnings report the stock price went up 5.886%.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in IT:1CVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CVS Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€97.07 (2.51% Upside)
€97.07 (2.51% Upside)
Blogger Sentiment
Bullish
IT:1CVS Sentiment 84%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth €281.2M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
89.21%
12-Months-Change
Fundamentals
Return on Equity
2.56%
Trailing 12-Months
Asset Growth
-1.02%
Trailing 12-Months
Company Description
CVS Health Corp
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
1CVS Company Deck
1CVS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a generally positive tone driven by clear top-line growth, strong cash generation, profit and EPS beats, an upward revision to full-year EPS guidance, meaningful improvement at Aetna (material AOI gain and operational efficiencies), and ongoing technology/AI initiatives (Health100). Offsetting risks include segment-level profit declines (Health Services and PCW), membership impacts from the Individual Exchange exit, continued elevated medical cost trends, PBM rebate pressures and regulatory/state-level uncertainty. On balance, the favorable operating metrics, raised guidance, and credible path to margin recovery outweighed the identifiable challenges.View all IT:1CVS earnings summaries1CVS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other
1CVS Stock 12 Month Forecast
Average Price Target
€97.07
▲(2.51% Upside)